A novel synthetic DNA minor groove binder, MS-247: Antitumor activity and cytotoxic mechanism

Cancer Chemotherapy and Pharmacology

Volumn 46, Issue 1, 2000, Pages 1-9

  Matsuba, Y ^a   Edatsugi, H ^a   Mita, I ^b   Matsunaga, A ^b   Nakanishi, O ^a  

^a Institute of Biological Science Mitsui Pharmaceuticals Inc   (Japan)

^b MITSUI CHEMICALS INC   (Japan)

Author keywords

Antitumor effect; DNA minor groove binder; DNA DNA interstrand crosslinks; MS 247; Netropsin

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; MS 247; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; COLON CARCINOMA; CYTOTOXICITY; DNA DNA HYBRIDIZATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033947098     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000120     Document Type: Article

References (25)

1. 1. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589
2. 2. Arcamone FM, Animati F, Barbieri B, Configliacci E, D'Alessio R, Geroni C, Giuliani FC, Lazzari E, Menozzi M, Mongelli N, Penco S, Verini MA (1989) Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives. J Med Chem 32: 774
3. 3. Atwell GJ, Yaghi BM, Turner PR, Boyd M, O'Connor CJ, Ferguson LR, Baguley BC, Denny WA (1995) Synthesis, DNA interactions and biological activity of DNA minor groove targeted polybenzamide-linked nitrogen mustards. Bioorg Med Chem 3: 679
4. 4. Bhuyan BK, Smith KS, Adams EG, Wallace TL, Von Hoff DD, Li LH (1992) Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects. Cancer Chemother Pharmacol 30: 348
5. 5. Broggini M, Erba E, Ponti M, Ballinari D, Geroni C, Spreafico F, D'Incalci M (1991) Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Res 51: 199
6. 6. Carter CA, Waud WR, Li LH, DeKoning TF, McGovren JP, Plowman J (1996) Preclinical antitumor activity of bizelesin in mice. Clin Cancer Res 2: 1143
7. 7. Chen AY, Yu C, Gatto B, Liu LF (1993) DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proc Natl Acad Sci USA 90: 8131
8. 8. Geroni C, Pesenti E, Tagliabue G, Ballinari D, Mongelli N, Broggini M, Erba E, D'Incalci M, Spreafico F, Grandi M (1993) Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies. Int J Cancer 53: 308
9. 9. Herzig MCS, Trevino AV, Arnett BM, Woynarowski JM (1998) Site-and region-specificity of tallimustine lesions in cellular DNA (abstract). Tenth NCI-EORTC Symposium on New Drugs in Cancer Therapy, p 137
10. 10. Jiang BZ, Bank BB, Hsiang YH, Shen T, Prtmesil M, Silber R (1989) Lack of drug-induced DNA cross-links in chlorambucil-resistant Chinese hamster ovary cells. Cancer Res 49: 5514
11. 11. Kobayashi E, Okamoto A, Asada M, Okabe M, Nagamura S, Asai A, Saito H, Gomi K, Hirata T (1994) Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors. Cancer Res 54: 2404
12. 12. Kohn KW, Ewing RAG, Erickson LC, Zwelling LA (1981) Measurement of strand breaks and crosslinks by alkaline elution. In: Friedberg EC, Hanawalt PC (eds) DNA repair. A laboratory manual of research procedures. Marcel Dekker, New York, p 379
13. 13. Li LH, Kelly RC, Warpehoski MA, McGovren JP, Gebhard I, DeKoning TF (1991) Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065. Invest New Drugs 9: 137
14. 14. Loontiens FG, Regenfuss P, Zechel A, Dumortier L, Clegg RM (1990) Binding characteristics of Hoechst 33258 with calf thymus DNA, poly[d(A-T)], and d(CCGGAATTCCGG): multiple stoichiometries and determination of tight binding with a wide spectrum of site affinities. Biochemistry 29: 9029
15. 15. Martin DG, Biles C, Gerpheide SA, Hanka LJ, Krueger WC, McGovren JP, Mizsak SA, Neil GL, Stewart JC, Visser J (1981) CC-1065 (NSC 298223), a potent new antitumor agent. Improved production and isolation, characterization and antitumor activity. J Antibiot (Tokyo) 34: 1119
16. 16. Matsunaga A, Mita Y, Kohno H, Edatsugi I, Iwata D (1998) Sulfonium salts of tyrrolylbenzimidazoles. US Patent No. 5808087
17. 17. Parkinson JA, Barber J, Douglas KT, Rosamond J, Sharpies D (1990) Minor-groove recognition of the self-complementary duplex d(CGCGAATTCGCG)2 by Hoechst 33258: a high-field NMR study. Biochemistry 29: 10181
18. 18. Pezzoni G, Grandi M, Biasoli G, Capolongo L, Ballinari D, Giuliani FC, Barbieri B, Pastori A, Pesenti E, Mongelli N, Spreafico F (1991) Biological profile of FCE24517, a novel benzoyl mustard analogue of distamycin A. Br J Cancer 64: 1047
19. 19. Pratt WB, Ruddon RW, Ensminger WD, Maybaum J (1994) Covalent DNA-binding drugs. In: Pratt WB, Ruddon RW (eds) The anticancer drugs. Oxford University Press, New York, pp 108-154
20. 20. Pratt WB, Ruddon RW, Ensminger WD, Maybaum J (1994) Noncovalent DNA-binding drugs. In: Pratt WB, Ruddon RW (eds) The anticancer drugs. Oxford University Press, New York, pp 170-173
21. 21. Sandhu LC, Warters RL, Dethlefsen LA (1985) Fluorescence studies of Hoechst 33342 with supercoiled and relaxed plasmid pBR322 DNA. Cytometry 6: 191
22. 22. Sriram M, Marel GA van der, Roelen HL, Boom JH van, Wang AH (1992) Conformation of B-DNA containing O6-ethyl-G-C base pairs stabilized by minor groove binding drugs: molecular structure of d(CGC[e6G]AATTCGCG complexed with Hoechst 33258 or Hoechst 33342. EMBO J 11: 225
23. 23. Turner PR, Denny WA (1996) The mutagenic properties of DNA minor-groove binding ligands. Mutat Res 355: 141
24. 24. Walker DL, Reid JM, Ames MM (1993) Preclinical pharmacology of bizelesin (NSC-615291): a potent bifunctional analog of CC-1065 and adozelesin. Proc Am Assoc Cancer Res 34: 376
25. 25. Yamori T, Matsunaga A, Sato S, Yamazaki K, Komi A, Ishizu K, Mita I, Edatsugi H, Matsuba Y, Takezawa K, Nakanishi O, Kohno H, Nakajima Y, Komatsu H, Andoh T, Tsuruo T (1999) Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res 59: 4042